FEDERALhearing transcript

Congressional Hearing on Ebola Eradication Efforts

Original title: ERADICATING EBOLA: LESSONS LEARNED AND MEDICAL ADVANCEMENTS

January 1, 2019

Ebola Global Health Public Health Vaccines International Relations Disease Control

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

This hearing informs federal policy and funding decisions regarding international disease response, which directly impacts the allocation of U.S. resources to combat global health threats like Ebola.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

USAID

The agency provides personnel and resources for international health responses.

Centers for Disease Control and Prevention

The agency leads medical and scientific efforts to track and contain the virus.

What changed

Last recorded activity January 1, 2019.

What's next

Next step not available in the current record.

Summary

The House on Africa, Global Health, Global Human Rights, and International Organizations held a hearing to review strategies for eradicating Ebola. The session focused on recent medical advancements, such as new vaccines, and the ongoing challenges of managing outbreaks in conflict-prone regions.

Key Facts

The hearing took place on June 4, 2019, in the Rayburn House Office Building.
The 2019 Ebola outbreak in the Democratic Republic of the Congo reached over 2,000 cases and nearly 1,200 deaths as of the hearing date.
The 2014-2016 Ebola outbreak resulted in 28,000 total cases and 11,000 deaths.
New medical advancements discussed include the development of an Ebola vaccine and improved healthcare worker training.
Outbreak response is currently hindered by regional conflict, community distrust, and attacks on treatment centers.
The subcommittee allows members 5 days to submit additional statements or questions for the record.

Frequently Asked Questions

What is the purpose of this hearing?

The hearing was held to discuss the status of the Ebola outbreak, evaluate medical advancements like vaccines, and identify challenges in eradicating the disease.

Why is the current Ebola outbreak difficult to control?

According to the testimony, the outbreak is complicated by regional conflict, a lack of trust between local communities and medical practitioners, and armed groups attacking treatment centers.

Why It Matters

This hearing informs federal policy and funding decisions regarding international disease response, which directly impacts the allocation of U.S. resources to combat global health threats like Ebola.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Vaccine Deployment

The hearing marks a shift in focus from general containment to the specific integration of new vaccine technology in active outbreak zones.

Centers for Disease Control and Prevention

Connected Entities

personChristopher Smith“Ranking Member of the Subcommittee”Map →

personTim Ziemer“Acting Assistant Administrator, USAID”Map →

locationDemocratic Republic of the Congo“Site of the 2019 Ebola outbreak”Map →

personRobert Redfield“Director, Centers for Disease Control and Prevention”Map →

personKaren Bass“Chair of the Subcommittee on Africa, Global Health, Global Human Rights, and Int”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance65
How much this matters to a regular citizen
Controversy20
Intensity of disagreement among stakeholders
Entertainment10
Compellingness for a non-policy-wonk reader
Buzz15
Current news / social attention level

Publisher tools